PI
KRYS icon

Putnam Investments’s Krystal Biotech KRYS Stock Holding History

Putnam Investments’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$4.88M Buy
39,322
+4,529
+13% +$502K 0.01% 443
2023
Q3 		$4.04M Buy
34,793
+19,641
+130% +$2.4M 0.01% 478
2023
Q2 		$1.78M Buy
+15,152
New +$1.55M ﹤0.01% 762

Other funds holding KRYS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Putnam Investments's KRYS Position: Q4 2023 in Review

Putnam Investments increased its Krystal Biotech (KRYS) stake by 13% in Q4 2023, buying an estimated $502K and bringing the position to 39,322 shares worth $4.88M. The position accounts for 0.01% of the portfolio, ranked #443.

Putnam Investments first reported a position in KRYS in Q2 2023 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold KRYS as of Q4 2023.

  • Putnam Investments held 39,322 shares of Krystal Biotech worth $4.88M as of Q4 2023.
  • Putnam Investments bought 4,529 Krystal Biotech shares in Q4 2023, an estimated $502K.
  • Krystal Biotech made up 0.01% of Putnam Investments's portfolio in Q4 2023, its #443 holding.
  • Putnam Investments first reported a position in Krystal Biotech in Q2 2023 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.